Publications

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

Preferences

Statistics

Marketing

A standardized in vivo platform for preclinical screening of therapeutic interventions in rat thoracic spinal cord injury

A systematic assessment of robustness in CNS safety pharmacology.

Filters

Filters

Therapeutic Areas

Specific Disorders

Filters

The GBA1 D409V Mutation Exacerbates Synuclein Pathology to Differing Extents in two Alpha-Synuclein Models

Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake

Use of Phenotypic Screening in Mice in the Development of a Novel Non-D2-Receptor-Targeting Drug for the Treatment of Schizophrenia

Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex

Transcriptional Assessment of Striatal mRNAs as Valid Biomarkers of Disease Progression in Three Mouse Models of Huntington’s Disease

Mouse model systems of autism spectrum disorder: Replicability and informatics signature

Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals

ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

Let’s Find the Right Solution Together

Quick Links

Contact

Address

Email

Phone

Fax